Cumulative smoking dose affects the clinical outcomes of EGFR-mutated lung adenocarcinoma patients treated with EGFR-TKIs: a retrospective study

BACKGROUND: Although lung adenocarcinoma with activating epidermal growth factor receptor (EGFR) mutations is common in never smokers, one-third of the patients are ever-smokers. We aimed to investigate the effect of cumulative smoking dose(CSD) on clinical outcomes, including progression-free survi...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, In Ae, Lee, Jong Sik, Kim, Hee Joung, Kim, Wan Seop, Lee, Kye Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6064083/
https://www.ncbi.nlm.nih.gov/pubmed/30055587
http://dx.doi.org/10.1186/s12885-018-4691-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6064083/
https://www.ncbi.nlm.nih.gov/pubmed/30055587
http://dx.doi.org/10.1186/s12885-018-4691-0

Ejemplares similares